NEO
Diagnostics & Research · Healthcare
CFO
Equibles does not estimate personal net worth.
Kathryn B. McKenzie was last confirmed as CFO at Neogenomics Inc (NEO) in a filing dated April 14, 2022. The proxy statement of Neogenomics Inc reports total compensation of $1,034,616 for Kathryn B. McKenzie in fiscal 2020, including a base salary of $359,616. Disclosed compensation is on record for 4 fiscal years. Kathryn B. McKenzie has spoken on 7 earnings calls across 1 company, most recently for Neogenomics Inc on November 4, 2021. The companies whose calls Kathryn B. McKenzie spoke on are classified in the Healthcare sector.
“Revenue excluding COVID-19 PCR testing grew 12% year-over-year to $121 million in quarter three. Clinical revenues of $102 million represented 11% year-over-year growth excluding COVID-19 PCR testing.”
“Second quarter clinical division revenue grew 37% year-over-year, driven by a strong bounce back in clinical volume compared to the depressed volumes during the initial wave of the pandemic in the second quarter last year.”
“Despite the impact of the ongoing pandemic, total revenue in Q1 grew 9% year-over-year to $116 million. Importantly, our core oncology revenues increased 7% year-over-year, driven by strong growth in NGS, Pharma Services and Informatics.”
“As Doug highlighted, overall revenue grew 18% year-over-year to $126 million. Importantly, our core oncology revenues increased 10% year-over-year driven by strong growth in NGS, Pharma Services, and Informatics.”
“As Doug highlighted, overall revenue grew 44% sequentially and 20% year-over-year to $125 million. Clinical Division revenues increased 17% year-over-year, boosted significantly by the contribution from COVID-19 PCR testing.”
Start not stated–2022-04-14
Last confirmed by a filing; no departure on record
NEO
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Neogenomics Inc (NEO) | Chief Financial Officer | $359,616 | $1,034,616 |
| 2019 | Neogenomics Inc (NEO) | Chief Financial Officer | $250,000 | $524,844 |
| 2018 | Neogenomics Inc (NEO) | Chief Financial Officer | — | — |
| 2017 | Neogenomics Inc (NEO) | Vice President and Chief Accounting Officer (Principal Financial Officer) | — | — |